A Global Guide to Compound Management
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
In this special report, we asked compound management leaders from Merck, GSK, Genentech and elsewhere to share insight on their main focus areas. Topics discussed: HTS, Controlled Substances, Collaborations, Biologics and Nanotechnology.
Have Your Say
Rate this feature and give us your feedback in the comments section below
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.